D-Index & Metrics Best Publications
Marc Boogaerts

Marc Boogaerts

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 70 Citations 22,682 299 World Ranking 17406 National Ranking 212

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Chemotherapy

His scientific interests lie mostly in Internal medicine, Surgery, Transplantation, Gastroenterology and Myelodysplastic syndromes. Marc Boogaerts has researched Internal medicine in several fields, including Aspergillosis and Oncology. His studies deal with areas such as Cancer, Amphotericin B and Predictive value of tests as well as Surgery.

His work deals with themes such as ST elevation, Stem cell, Myocardial infarction complications and Percutaneous coronary intervention, which intersect with Transplantation. His Gastroenterology study incorporates themes from Bone marrow failure, Incidence, Absolute neutrophil count, Immunology and Complication. In his study, Hazard ratio is inextricably linked to Retrospective cohort study, which falls within the broad field of Myelodysplastic syndromes.

His most cited work include:

  • A Tyrosine Kinase Created by Fusion of the PDGFRA and FIP1L1 Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic Syndrome (1452 citations)
  • Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. (1202 citations)
  • Efficacy and Safety of Caspofungin for Treatment of Invasive Aspergillosis in Patients Refractory to or Intolerant of Conventional Antifungal Therapy (559 citations)

What are the main themes of his work throughout his whole career to date?

Internal medicine, Immunology, Surgery, Transplantation and Gastroenterology are his primary areas of study. His research investigates the link between Internal medicine and topics such as Oncology that cross with problems in Survival rate. His Immunology study frequently draws connections between related disciplines such as Pharmacology.

His research in Surgery intersects with topics in Amphotericin B, Aspergillosis and Urology. His studies in Transplantation integrate themes in fields like Stem cell, Median follow-up, Disease and Lymphoma. His Gastroenterology research is multidisciplinary, incorporating elements of Total body irradiation, Adverse effect, Survival analysis and Mycosis.

He most often published in these fields:

  • Internal medicine (44.11%)
  • Immunology (29.63%)
  • Surgery (21.55%)

What were the highlights of his more recent work (between 2005-2016)?

  • Internal medicine (44.11%)
  • Surgery (21.55%)
  • Transplantation (17.51%)

In recent papers he was focusing on the following fields of study:

Marc Boogaerts mainly focuses on Internal medicine, Surgery, Transplantation, Immunology and Hematopoietic stem cell transplantation. His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology, Oncology and Cardiology. His Surgery research incorporates elements of Obstetrics and Urology.

His studies deal with areas such as Hematology, Stem cell, Median follow-up and Disease as well as Transplantation. His research in Immunology intersects with topics in Haematopoiesis, Bone marrow failure and In vivo. Marc Boogaerts has included themes like Chemotherapy, Performance status, Regimen, Retrospective cohort study and Leukemia in his Hematopoietic stem cell transplantation study.

Between 2005 and 2016, his most popular works were:

  • Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. (1202 citations)
  • Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes. (295 citations)
  • Reduced-Intensity Conditioning Compared With Conventional Allogeneic Stem-Cell Transplantation in Relapsed or Refractory Hodgkin's Lymphoma: An Analysis From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation (257 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Chemotherapy

Marc Boogaerts mostly deals with Internal medicine, Surgery, Transplantation, Myelodysplastic syndromes and Hematopoietic stem cell transplantation. His Internal medicine study incorporates themes from Stem cell, Oncology and Cardiology. His Surgery research is multidisciplinary, incorporating perspectives in Gastroenterology and Leukapheresis.

His Transplantation research is multidisciplinary, relying on both Carboplatin, Absolute neutrophil count, Granulocyte colony-stimulating factor and Urology. His Myelodysplastic syndromes research includes elements of T cell and Survival analysis. His Hematopoietic stem cell transplantation research integrates issues from Leukemia and Retrospective cohort study.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

A Tyrosine Kinase Created by Fusion of the PDGFRA and FIP1L1 Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic Syndrome

Jan Cools;Jan Cools;Daniel J. DeAngelo;Jason Gotlib;Elizabeth H. Stover.
The New England Journal of Medicine (2003)

2071 Citations

Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial.

Stefan Janssens;Christophe Dubois;Jan Bogaert;Koen Theunissen.
The Lancet (2006)

1676 Citations

Galactomannan and Computed Tomography–Based Preemptive Antifungal Therapy in Neutropenic Patients at High Risk for Invasive Fungal Infection: A Prospective Feasibility Study

Johan Maertens;Koen Theunissen;Gregor Verhoef;Johnny Verschakelen.
Clinical Infectious Diseases (2005)

797 Citations

Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients

N Schmitz;P Dreger;D.C Linch;A.H Goldstone.
The Lancet (1996)

785 Citations

Efficacy and Safety of Caspofungin for Treatment of Invasive Aspergillosis in Patients Refractory to or Intolerant of Conventional Antifungal Therapy

Johan Maertens;Issam Raad;George Petrikkos;Marc Boogaerts.
Clinical Infectious Diseases (2004)

767 Citations

Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation.

Johan Maertens;Jan Verhaegen;Katrien Lagrou;Johan Van Eldere.
Blood (2001)

722 Citations

Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network

Martin Dreyling;Georg Lenz;Eva Hoster;Achiel Van Hoof.
Blood (2004)

721 Citations

Prognostic Index for Adult Patients With Acute Myeloid Leukemia in First Relapse

Dimitri A. Breems;Wim L.J. Van Putten;Peter C. Huijgens;Gert J. Ossenkoppele.
Journal of Clinical Oncology (2005)

613 Citations

Autopsy-Controlled Prospective Evaluation of Serial Screening for Circulating Galactomannan by a Sandwich Enzyme-Linked Immunosorbent Assay for Hematological Patients at Risk for Invasive Aspergillosis

Johan Maertens;Jan Verhaegen;Hilde Demuynck;Penelope Brock.
Journal of Clinical Microbiology (1999)

536 Citations

Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia.

Bob Löwenberg;Wim van Putten;Matthias Theobald;Jurg Gmür.
The New England Journal of Medicine (2003)

490 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Marc Boogaerts

Thomas J. Walsh

Thomas J. Walsh

Weill Cornell Medicine

Publications: 83

Hagop M. Kantarjian

Hagop M. Kantarjian

The University of Texas MD Anderson Cancer Center

Publications: 75

H. Joachim Deeg

H. Joachim Deeg

Fred Hutchinson Cancer Research Center

Publications: 75

Ayalew Tefferi

Ayalew Tefferi

Mayo Clinic

Publications: 66

John R. Wingard

John R. Wingard

University of Florida

Publications: 61

Nicholas C.P. Cross

Nicholas C.P. Cross

University of Southampton

Publications: 60

Oliver A. Cornely

Oliver A. Cornely

University of Cologne

Publications: 60

Jan Cools

Jan Cools

KU Leuven

Publications: 59

Martin Dreyling

Martin Dreyling

Ludwig-Maximilians-Universität München

Publications: 55

Johan Maertens

Johan Maertens

KU Leuven

Publications: 54

Bob Löwenberg

Bob Löwenberg

Erasmus MC

Publications: 54

Raoul Herbrecht

Raoul Herbrecht

University of Strasbourg

Publications: 53

Arnold Ganser

Arnold Ganser

Hannover Medical School

Publications: 52

Jorge E. Cortes

Jorge E. Cortes

Augusta University

Publications: 52

Frederick R. Appelbaum

Frederick R. Appelbaum

Fred Hutchinson Cancer Research Center

Publications: 50

Andreas H. Groll

Andreas H. Groll

Boston Children's Hospital

Publications: 50

Trending Scientists

Elaine J. Weyuker

Elaine J. Weyuker

University of Central Florida

Zhong-Ren Peng

Zhong-Ren Peng

University of Florida

Jalel Labidi

Jalel Labidi

University of the Basque Country

Patrick Gamez

Patrick Gamez

University of Barcelona

Takatomo Sasaki

Takatomo Sasaki

Osaka University

Serena M. Best

Serena M. Best

University of Cambridge

Clenton E. Owensby

Clenton E. Owensby

Kansas State University

Matthias Wilmanns

Matthias Wilmanns

European Bioinformatics Institute

Ted H. Hansen

Ted H. Hansen

Washington University in St. Louis

Jai Sing Yang

Jai Sing Yang

China Medical University

Robert L. Metcalf

Robert L. Metcalf

University of Illinois at Urbana-Champaign

Giuseppe Matarese

Giuseppe Matarese

University of Naples Federico II

Steven M. Kawut

Steven M. Kawut

University of Pennsylvania

Peter Herscovitch

Peter Herscovitch

National Institutes of Health

Robert L. K. Tiong

Robert L. K. Tiong

Nanyang Technological University

Janet M. Turan

Janet M. Turan

University of Alabama at Birmingham

Something went wrong. Please try again later.